The forecasted number of prevalent tuberculosis cases in Canada remains fairly stable from 2024 to 2028, hovering around 2.25 to 2.26 thousand cases. These steady figures suggest a minimal decrease in TB occurrence, considering a slight 0.44% year-on-year decline from 2025 to 2026. The compound annual growth rate (CAGR) over the five-year forecast is approximately 0%, reflecting stability over time. In 2023, figures also stood at a comparable level, indicating no significant change over recent years.
Future trends to monitor include the impact of public health initiatives, vaccination rates, and potential drug resistance. Advances in healthcare technology and policy changes could further influence TB prevalence in Canada. Close observation of these factors will be essential to managing and ideally decreasing TB cases in coming years.
